Global Non-small Cell Lung Cancer Therapeutics Market Insights and Forecast to 2028

Global Non-small Cell Lung Cancer Therapeutics Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Alimta
1.2.3 Iressa
1.2.4 Avastin
1.2.5 Tarceva
1.2.6 Zykadia
1.2.7 Tagrisso
1.2.8 Xalkori
1.2.9 Cyramza
1.2.10 Opdivo
1.2.11 Alecensa
1.3 Market by Application
1.3.1 Global Non-small Cell Lung Cancer Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-small Cell Lung Cancer Therapeutics Market Perspective (2017-2028)
2.2 Non-small Cell Lung Cancer Therapeutics Growth Trends by Region
2.2.1 Non-small Cell Lung Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Non-small Cell Lung Cancer Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Non-small Cell Lung Cancer Therapeutics Market Dynamics
2.3.1 Non-small Cell Lung Cancer Therapeutics Industry Trends
2.3.2 Non-small Cell Lung Cancer Therapeutics Market Drivers
2.3.3 Non-small Cell Lung Cancer Therapeutics Market Challenges
2.3.4 Non-small Cell Lung Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-small Cell Lung Cancer Therapeutics Players by Revenue
3.1.1 Global Top Non-small Cell Lung Cancer Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Non-small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-small Cell Lung Cancer Therapeutics Revenue
3.4 Global Non-small Cell Lung Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Non-small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-small Cell Lung Cancer Therapeutics Revenue in 2021
3.5 Non-small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Non-small Cell Lung Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Non-small Cell Lung Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-small Cell Lung Cancer Therapeutics Breakdown Data by Type
4.1 Global Non-small Cell Lung Cancer Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2023-2028)
5 Non-small Cell Lung Cancer Therapeutics Breakdown Data by Application
5.1 Global Non-small Cell Lung Cancer Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-small Cell Lung Cancer Therapeutics Market Size (2017-2028)
6.2 North America Non-small Cell Lung Cancer Therapeutics Market Size by Type
6.2.1 North America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Non-small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
6.3 North America Non-small Cell Lung Cancer Therapeutics Market Size by Application
6.3.1 North America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Non-small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
6.4 North America Non-small Cell Lung Cancer Therapeutics Market Size by Country
6.4.1 North America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Non-small Cell Lung Cancer Therapeutics Market Size (2017-2028)
7.2 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type
7.2.1 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Non-small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
7.3 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application
7.3.1 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Non-small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
7.4 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country
7.4.1 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-small Cell Lung Cancer Therapeutics Market Size (2017-2028)
9.2 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type
9.2.1 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Non-small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application
9.3.1 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Non-small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country
9.4.1 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Non-small Cell Lung Cancer Therapeutics Introduction
11.2.4 Novartis Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Non-small Cell Lung Cancer Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
11.3.5 AstraZeneca Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Non-small Cell Lung Cancer Therapeutics Introduction
11.4.4 Roche Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
11.4.5 Roche Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Non-small Cell Lung Cancer Therapeutics Introduction
11.6.4 Pfizer Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
11.6.5 Pfizer Recent Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Non-small Cell Lung Cancer Therapeutics Introduction
11.7.4 Eli Lilly Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
11.7.5 Eli Lilly Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Non-small Cell Lung Cancer Therapeutics Introduction
11.8.4 Sanofi Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
11.8.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Non-small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Alimta
Table 3. Key Players of Iressa
Table 4. Key Players of Avastin
Table 5. Key Players of Tarceva
Table 6. Key Players of Zykadia
Table 7. Key Players of Tagrisso
Table 8. Key Players of Xalkori
Table 9. Key Players of Cyramza
Table 10. Key Players of Opdivo
Table 11. Key Players of Alecensa
Table 12. Global Non-small Cell Lung Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 13. Global Non-small Cell Lung Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 14. Global Non-small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 15. Global Non-small Cell Lung Cancer Therapeutics Market Share by Region (2017-2022)
Table 16. Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 17. Global Non-small Cell Lung Cancer Therapeutics Market Share by Region (2023-2028)
Table 18. Non-small Cell Lung Cancer Therapeutics Market Trends
Table 19. Non-small Cell Lung Cancer Therapeutics Market Drivers
Table 20. Non-small Cell Lung Cancer Therapeutics Market Challenges
Table 21. Non-small Cell Lung Cancer Therapeutics Market Restraints
Table 22. Global Non-small Cell Lung Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 23. Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Players (2017-2022)
Table 24. Global Top Non-small Cell Lung Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-small Cell Lung Cancer Therapeutics as of 2021)
Table 25. Ranking of Global Top Non-small Cell Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2021
Table 26. Global 5 Largest Players Market Share by Non-small Cell Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Non-small Cell Lung Cancer Therapeutics Product Solution and Service
Table 29. Date of Enter into Non-small Cell Lung Cancer Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 32. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2017-2022)
Table 33. Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 34. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2023-2028)
Table 35. Global Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 36. Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Application (2017-2022)
Table 37. Global Non-small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 38. Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Application (2023-2028)
Table 39. North America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 40. North America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 41. North America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 42. North America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 43. North America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 44. North America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 45. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 46. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 47. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 48. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 49. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 50. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 51. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 52. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 53. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 54. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 55. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 56. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 57. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 58. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 59. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 60. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 61. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 62. Latin America Non-small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 65. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 66. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 67. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 68. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product
Table 72. GlaxoSmithKline Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 73. GlaxoSmithKline Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Non-small Cell Lung Cancer Therapeutics Product
Table 77. Novartis Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Non-small Cell Lung Cancer Therapeutics Product
Table 82. AstraZeneca Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 83. AstraZeneca Recent Developments
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Non-small Cell Lung Cancer Therapeutics Product
Table 87. Roche Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 88. Roche Recent Developments
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Product
Table 92. Bristol-Myers Squibb Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 93. Bristol-Myers Squibb Recent Developments
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Non-small Cell Lung Cancer Therapeutics Product
Table 97. Pfizer Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 98. Pfizer Recent Developments
Table 99. Eli Lilly Company Details
Table 100. Eli Lilly Business Overview
Table 101. Eli Lilly Non-small Cell Lung Cancer Therapeutics Product
Table 102. Eli Lilly Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 103. Eli Lilly Recent Developments
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Non-small Cell Lung Cancer Therapeutics Product
Table 107. Sanofi Revenue in Non-small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 108. Sanofi Recent Developments
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-small Cell Lung Cancer Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Alimta Features
Figure 3. Iressa Features
Figure 4. Avastin Features
Figure 5. Tarceva Features
Figure 6. Zykadia Features
Figure 7. Tagrisso Features
Figure 8. Xalkori Features
Figure 9. Cyramza Features
Figure 10. Opdivo Features
Figure 11. Alecensa Features
Figure 12. Global Non-small Cell Lung Cancer Therapeutics Market Share by Application: 2021 VS 2028
Figure 13. Hospital Case Studies
Figure 14. Clinic Case Studies
Figure 15. Non-small Cell Lung Cancer Therapeutics Report Years Considered
Figure 16. Global Non-small Cell Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Non-small Cell Lung Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Non-small Cell Lung Cancer Therapeutics Market Share by Region: 2021 VS 2028
Figure 19. Global Non-small Cell Lung Cancer Therapeutics Market Share by Players in 2021
Figure 20. Global Top Non-small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-small Cell Lung Cancer Therapeutics as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Non-small Cell Lung Cancer Therapeutics Revenue in 2021
Figure 22. North America Non-small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. North America Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 24. North America Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 25. North America Non-small Cell Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
Figure 26. United States Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Canada Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe Non-small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 29. Europe Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 30. Europe Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 31. Europe Non-small Cell Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
Figure 32. Germany Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 39. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 40. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 41. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Size Share by Region (2017-2028)
Figure 42. China Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 48. Latin America Non-small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Latin America Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 50. Latin America Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 51. Latin America Non-small Cell Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
Figure 52. Mexico Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Brazil Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
Figure 58. Turkey Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UAE Non-small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 62. Novartis Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 63. AstraZeneca Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 64. Roche Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 66. Pfizer Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 67. Eli Lilly Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 68. Sanofi Revenue Growth Rate in Non-small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs